Dyne Therapeutics, Inc.
DYN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $574 | $485 | $472 | $435 |
| Short-Term Investments | $218 | $199 | $205 | $207 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $14 | $14 | $12 | $17 |
| Total Curr. Assets | $806 | $698 | $690 | $659 |
| Property Plant & Equip (Net) | $46 | $29 | $30 | $30 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $15 | $3 | $2 | $2 |
| Total NC Assets | $61 | $31 | $32 | $32 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $867 | $729 | $721 | $691 |
| Liabilities | – | – | – | – |
| Payables | $12 | $14 | $7 | $7 |
| Short-Term Debt | $5 | $5 | $5 | $5 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $43 | $22 | $22 | $31 |
| Total Curr. Liab. | $60 | $41 | $34 | $42 |
| LT Debt | $16 | $116 | $18 | $19 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $99 | $0 | $0 | $0 |
| Total NC Liab. | $115 | $116 | $18 | $19 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $22 | $23 | $24 |
| Total Liabilities | $175 | $158 | $52 | $61 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$1,284 | -$1,176 | -$1,065 | -$950 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $1,975 | $1,747 | $1,734 | $1,580 |
| Total Equity | $692 | $571 | $669 | $630 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $867 | $729 | $721 | $691 |
| Net Debt | -$552 | -$364 | -$449 | -$411 |